Assignee
GENAISSANCE PHARMACEUTICALS
US·10 granted patents·13 pending applications·536 citations·filing 1997–2005
Top patents by PatentIndex Score
23 records- 0194US6931326B1Methods for obtaining and using haplotype dataGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Aug 16, 2005·136 cites·37 claims
- 0292US7058517B1Methods for obtaining and using haplotype dataGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Jun 6, 2006·161 cites·4 claims
- 0386US6521747B2Haplotypes of the AGTR1 geneGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Feb 18, 2003·59 cites·32 claims
- 0485US6232076B1Stabilizer of dye sequencing productsGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted May 15, 2001·22 cites·21 claims
- 0584US6797477B2Genetic typing of the human cytochrome P450 2A6 gene and related methodsGENAISSANCE PHARMACEUTICALS·Filed 2002·Granted Sep 28, 2004·10 cites·10 claims
- 0680US6797472B1Variation in drug response related to polymorphisms in β2-adrenergic receptorGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Sep 28, 2004·7 cites·4 claims
- 0779US6586183B2Association of β2-adrenergic receptor haplotypes with drug responseGENAISSANCE PHARMACEUTICALS·Filed 2001·Granted Jul 1, 2003·13 cites·10 claims
- 0878US6944767B1Methods and apparatus for ensuring the privacy and security of personal medical informationGENAISSANCE PHARMACEUTICALS·Filed 2000·Granted Sep 13, 2005·34 cites·9 claims
- 0978US5972614AGenome anthologies for harvesting gene variantsGENAISSANCE PHARMACEUTICALS·Filed 1997·Granted Oct 26, 1999·80 cites·4 claims
- 1055US6861217B1Variation in drug response related to polymorphisms in the β2-adrenergic receptorGENAISSANCE PHARMACEUTICALS·Filed 1999·Granted Mar 1, 2005·14 cites·2 claims
- 1148US2005255495A1SLC5A7 genetic markers associated with age of onset of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1247US2006166219A1NTRK1 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1347US2005250122A1APOA4 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1447US2005255492A1CHRNA9 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1547US2005260613A1LRPAP1 genetic markers associated with galantamineGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1647US2005250118A1EPHX2 Genetic markers associated with galantamineGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1747US2005250121A1NTRK2 genetic markers associated with progression of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1847US2005255488A1NTRK1 genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1941US2003165844A1Haplotypes of the TNFRSF1A geneGENAISSANCE PHARMACEUTICALS·Filed 2001·Application pending·0 cites
- 2037US2006154265A1LDLR genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2137US2005277129A1APOE genetic markers associated with age of onset of Alzheimer's diseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2237US2005255498A1APOC1 genetic markers associated with age of onset of Alzheimer's DiseaseGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2336US2008020383A1Haplotype Markers And Methods Of Using The Same To Determine Response To TreatmentGENAISSANCE PHARMACEUTICALS·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →